Nebulized Bupivacaine Analgesia for Cleft Palate Repair

• Status: Recruiting
• Trial end date: 2021-11-15
• Target enrollment: 0
• Participant gender: All

Summary

In this study we introduce a potent local anesthetic; bupivacaine 0.5% in two different doses by nebulization as a preemptive analgesia to compare efficacy and safety in children with cleft palate repair.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Children (age 1-7 years) of American Society of Anaesthesiologists physical status (ASA) I-II

• Elective cleft palate repair ± cleft lip surgery under general anesthesia .

Exclusion Criteria:

• Coronary artery disease

• Hypertension

• Developmental delay

• Allergy to study drug